Why the Monadelphous share price is up 3% after meeting guidance

Engineering group Monadelphous Group Limited (ASX: MND) has seen its revenue and profit drop as expected after the completion of a major project in the prior period.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Engineering group Monadelphous Group Limited (ASX: MND) has announced its interim results, meeting revenue guidance and signalling a positive outlook for the remainder of the fiscal year.

The group met revenue guidance of $830.5 million, which represents a 5% decrease on the previous corresponding period. This decrease was primarily due to a fall in construction revenues as a result of the completion of a major project in the prior period and the timing of new project opportunities.

Maintenance revenues saw a significant increase and there was a growing contribution from infrastructure markets with an increase in new contracts won. The group also saw increased offshore oil and gas contracts activity and growing demand in the resources sector.

Net profit after tax of $30.7 million was 18.3% lower than the previous corresponding period as a result of lower revenues, increased depreciation and a reduction in interest income.

"Overall, the long-term outlook for Monadelphous remains positive as operating conditions continue to strengthen and the pipeline of resources construction opportunities gains in number," said Managing Director Rob Velletri in a statement.

Strengthening conditions in the resource and energy sectors were highlighted, with infrastructure investment said to be at a "healthy" level.

The company stated that it is in a favourable position to secure new work on major projects going forward, which it expects will "generate significant revenue in 2019/20 and beyond".

The company announced a 25 cents per share fully franked dividend to be paid on the 29 March.

Motley Fool contributor Cale Kalinowski has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »